In this comprehensive article, we lay down insights on the gut-lung axis, a detailed perspective on the existing correlation between gut microbiome and lung cancer, with a special focus on the role of pleiotropic cytokines, IL-6 and IL-17, in regulating this axis in NSCLC development (Figure 1). This evidence concerns the gene IL6 and lung cancer.